De Lisle Partners LLP Purchases 3,029 Shares of Kewaunee Scientific Corporation $KEQU

De Lisle Partners LLP lifted its position in Kewaunee Scientific Corporation (NASDAQ:KEQU) by 6.7% in the second quarter, according to its most recent filing with the Securities and Exchange Commission. The institutional investor owned 47,977 shares of the technology company’s stock after purchasing an additional 3,029 shares during the quarter. De Lisle Partners LLP’s holdings in Kewaunee Scientific were worth $2,811,000 at the end of the most recent quarter.

Other large investors also recently modified their holdings of the company. Bank of America Corp DE lifted its position in Kewaunee Scientific by 2,605.9% in the 4th quarter. Bank of America Corp DE now owns 460 shares of the technology company’s stock worth $28,000 after buying an additional 443 shares during the last quarter. Wedbush Securities Inc. purchased a new position in shares of Kewaunee Scientific during the second quarter worth approximately $232,000. Morgan Dempsey Capital Management LLC lifted its holdings in shares of Kewaunee Scientific by 41.8% in the 2nd quarter. Morgan Dempsey Capital Management LLC now owns 4,229 shares of the technology company’s stock worth $247,000 after acquiring an additional 1,247 shares during the last quarter. OMERS ADMINISTRATION Corp purchased a new stake in shares of Kewaunee Scientific in the 1st quarter valued at $284,000. Finally, Jane Street Group LLC boosted its stake in shares of Kewaunee Scientific by 65.8% in the 1st quarter. Jane Street Group LLC now owns 8,052 shares of the technology company’s stock valued at $317,000 after purchasing an additional 3,196 shares in the last quarter. 32.69% of the stock is owned by hedge funds and other institutional investors.

Insider Buying and Selling

In related news, VP Elizabeth D. Phillips sold 6,880 shares of the business’s stock in a transaction dated Thursday, October 2nd. The stock was sold at an average price of $43.20, for a total transaction of $297,216.00. Following the transaction, the vice president owned 8,248 shares in the company, valued at $356,313.60. The trade was a 45.48% decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. Also, CFO Donald T. Gardner III sold 3,000 shares of the company’s stock in a transaction that occurred on Thursday, October 9th. The shares were sold at an average price of $42.76, for a total value of $128,280.00. Following the transaction, the chief financial officer directly owned 11,564 shares of the company’s stock, valued at $494,476.64. The trade was a 20.60% decrease in their position. The disclosure for this sale is available in the SEC filing. Insiders have sold 15,880 shares of company stock valued at $689,471 over the last ninety days. 13.30% of the stock is owned by insiders.

Analyst Ratings Changes

Separately, Weiss Ratings reiterated a “hold (c+)” rating on shares of Kewaunee Scientific in a research report on Wednesday, October 8th. One investment analyst has rated the stock with a Hold rating, According to MarketBeat.com, the company presently has an average rating of “Hold”.

Kewaunee Scientific Stock Up 0.6%

Shares of Kewaunee Scientific stock opened at $38.58 on Friday. The company has a debt-to-equity ratio of 0.88, a quick ratio of 1.63 and a current ratio of 2.32. Kewaunee Scientific Corporation has a 52-week low of $30.33 and a 52-week high of $71.33. The company’s 50 day moving average price is $42.05 and its 200-day moving average price is $46.87. The stock has a market capitalization of $110.56 million, a price-to-earnings ratio of 9.34 and a beta of 0.64.

Kewaunee Scientific (NASDAQ:KEQU) last announced its quarterly earnings results on Wednesday, September 10th. The technology company reported $1.10 earnings per share for the quarter. The business had revenue of $71.10 million during the quarter. Kewaunee Scientific had a net margin of 4.68% and a return on equity of 25.65%.

About Kewaunee Scientific

Kewaunee Scientific Corporation designs, manufactures, and installs laboratory, healthcare, and technical furniture and infrastructure products. The company operates through two segments, Domestic and International. Its products include steel and wood casework, fume hoods, adaptable modular systems, moveable workstations, stand-alone benches, biological safety cabinets, and epoxy resin work surfaces and sinks.